Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus

Psychoneuroendocrinology

Volumn 33, Issue 3, 2008, Pages 395-403

  Nishimura, Katsuji ^a   Harigai, Masayoshi ^b   Omori, Masako ^a   Sato, Eri ^a   Hara, Masako ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Blood brain barrier; Central nervous system lupus; Complements; Corticosteroid induced psychiatric disorders; Qalbumin; Systemic lupus erythematosus

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE;

ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID INDUCED PSYCHIATRIC DISORDER; CORTICOSTEROID RELEASE; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADRENAL CORTEX HORMONES; ADULT; ALBUMINS; BLOOD-BRAIN BARRIER; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 39149122809     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.12.007     Document Type: Article

References (33)

1. Abbott N.J., Mendonça L.L., and Dolman D.E. The blood-brain barrier in systemic lupus erythematosus. Lupus 12 (2003) 908-915
2. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42 (1999) 599-608
3. Ainiala H., Loukkola J., Peltola J., Korpela M., and Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57 (2001) 496-500
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. forth ed (1994), American Psychiatric Association, Washington, DC
5. Andersson M., Alvarez-Cermeño J., Bernardi G., Cogato I., Fredman P., Frederiksen J., Fredrikson S., Gallo P., Grimaldi L.M., Grønning M., Keir G., Lamers K., Link H., Magalhães A., Massaro A.R., Öhman S., Reiber H., Rönnbäck L., Schluep M., Schuller E., Sindic C.J.M., Thompson E.J., Trojano M., and Wurster U. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J. Neurol. Neurosurg. Psychiatry 57 (1994) 897-902
6. Ballok D.A., Earls A.M., Krasnik C., Hoffman S.A., and Sakic B. Autoimmune-induced damage of the midbrain dopaminergic system in lupus-prone mice. J. Neuroimmunol. 152 (2004) 83-97
7. Brey R.L., Holliday S.L., Saklad A.R., Navarrete M.G., Hermosillo-Romo D., Stallworth C.L., Valdez C.R., Escalante A., del Rincon I., Gronseth G., Rhine C.B., Padilla P., and McGlasson D. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58 (2002) 1214-1220
8. Chau S.Y., and Mok C.C. Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 61 (2003) 104-107
9. Chrousos G.P., and Margioris A.N. Adrenocorticosteroids and adrenocortical antagonists. In: Katzung B.G. (Ed). Basic and Clinical Pharmacology (2001), Lange Medical Books/McGraw-Hill, New York 660-678
10. Denburg S.D., Carbotte R.M., and Denburg J.A. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum. 37 (1994) 1311-1320
11. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
12. Garcia-Moreno J.M., and Chacon J. Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature. Mov. Disord. 17 (2002) 1329-1335
13. Hanly J.G., McCurdy G., Fougere L., Douglas J.-A., and Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J. Rheumatol. 31 (2004) 2156-2162
14. Hirohata S., and Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 33 (1990) 644-649
15. Huerta P.T., Kowal C., DeGiorgio L.A., Volpe B.T., and Diamond B. Immunity and behavior: antibodies alter emotion. Proc. Natl. Acad. Sci. USA 103 (2006) 678-683
16. Joels M., and de Kloet E.R. Control of neuronal excitability by corticosteroid hormones. Trends Neurosci. 15 (1992) 25-30
17. Kelly M.C., and Denburg J.A. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions. J. Rheumatol. 14 (1987) 740-744
18. Kohen M., Asherson R.A., Gharavi A.E., and Lahita R.G. Lupus psychosis: differentiation from the steroid-induced state. Clin. Exp. Rheumatol. 11 (1993) 323-326
19. Lipowski Z.J. Delirium: Acute Confusional State (1990), Oxford University Press, New York
20. López-Medrano F., Cervera R., Trejo O., Font J., and Ingelmo M. Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level. Ann. Rheum. Dis. 61 (2002) 562-563
21. McLean B.N., Miller D., and Thompson E.J. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet's disease involving the nervous system. J. Neurol. Neurosurg. Psychiatry 58 (1995) 548-554
22. Oda K., Matsushima E., Okubo Y., Ohta K., Murata Y., Koike R., Miyasaka N., and Kato M. Abnormal regional cerebral blood flow in systemic lupus erythematosus patients with psychiatric symptoms. J. Clin. Psychiatry 66 (2005) 907-913
23. Patten S.B., and Neutel C.I. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf. 22 (2000) 111-122
24. Rosenberg G.A., Dencoff J.E., Correa Jr. N., Reiners M., and Ford C.C. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46 (1996) 1626-1632
25. Shiozawa S., Kuroki Y., Kim M., Hirohata S., and Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum. 35 (1992) 417-422
26. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., and Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271-1277
27. Trysberg E., Carlsten H., and Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 9 (2000) 498-503
28. Trzepacz P.T., Baker R.W., and Greenhouse J. A symptom rating scale for delirium. Psychiatry Res. 23 (1988) 89-97
29. West S.G. Neuropsychiatric lupus. Rheum. Dis. Clin. North Am. 20 (1994) 129-158
30. Winfield J.B., Shaw M., Silverman L.M., Eisenberg R.A., Wilson III H.A., and Koffler D. Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am. J. Med. 74 (1983) 837-844
31. Wolkowitz O.M. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology 19 (1994) 233-255
32. Wolkowitz O.M., Reus V.I., Canick J., Levin B., and Lupien S. Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann. N. Y. Acad. Sci. 823 (1997) 81-96
33. Wysenbeek A.J., Leibovici L., and Zoldan J. Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus. J. Rheumatol. 17 (1990) 1695-1696